Upon examining the fundamentals of Canada-based Tilray Brands, Inc. (TLRY) and Denmark-based Novo Nordisk A/S (NVO) in this article, it becomes evident that NVO possesses greater growth potential. Prior to delving into the reasons behind my optimism for NVO, let us explore the outlook for the pharma industry.
With the global population expanding and individuals encountering novel health challenges, the pharmaceutical sector reaps the rewards. Pharmaceutical market revenue is projected to reach $1.16 trillion in 2023.
